| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/04/2004 | EP1442739A1 Use of mono- or diesters of cinnamic acid or of one of its derivatives and vitamin C, as an NO donor |
| 08/04/2004 | EP1442737A2 Use of a (dihydro)jasmonic acid derivative for dry skin treatment |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442121A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 08/04/2004 | EP1442066A1 Compositions comprising chitosan in the form of nano-sized fibres |
| 08/04/2004 | EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442032A1 Heterocyclic retinoid compounds |
| 08/04/2004 | EP1442024A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 08/04/2004 | EP1442021A1 Substituted 1h-quinolin-2-one compounds |
| 08/04/2004 | EP1442020A1 Heterocyclic derivatives of glycinamide and their medical use |
| 08/04/2004 | EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/04/2004 | EP1441772A2 Polymer conjugates of protein kinase c inhibitors |
| 08/04/2004 | EP1441767A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441755A2 Topical use of cytokines and chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases |
| 08/04/2004 | EP1441747A2 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition |
| 08/04/2004 | EP1441746A1 Composition and method |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441731A1 Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441692A2 Composition containing an amino acid n-acylated ester and a polyamide-structured uv filter |
| 08/04/2004 | EP1441685A2 Anti-irritating rosacea treatment |
| 08/04/2004 | EP1441635A2 Sterile, breathable patch for treating wound pain |
| 08/04/2004 | EP1401275A4 Antiviral composition and treatment method |
| 08/04/2004 | EP1361850A4 Use of (gamma-hydroxy-n-methyl-l-leucine9) cyclosporin a for hair growth |
| 08/04/2004 | EP1289945B1 Aniline disulfide derivatives for treating allergic diseases |
| 08/04/2004 | EP1280806B1 THIENO 2,3-d]PYRIMIDINEDIONES AND THEIR USE AS PHARMACEUTICALS |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1171151A4 Thrombospondin-2 and uses thereof |
| 08/04/2004 | EP1169054B1 Prognosis of ptp lar related diseases |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1127071B1 Compounds with growth hormone releasing properties |
| 08/04/2004 | EP1112262B1 Substituted gamma-phenyl-delta-lactones and analogs thereof and uses related thereto |
| 08/04/2004 | CN1518604A Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto |
| 08/04/2004 | CN1518552A Pyrrolopyrimidines as protein kinase inhitibors |
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518545A Novel, ascorbic acid compounds, methods of synthesis and application use thereof |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518469A Dermatological formulations |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518459A Remedies for eosinophilic diseases |
| 08/04/2004 | CN1518451A Identifying and treatment of purastic fungi of organism |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1518439A Cosmetics |
| 08/04/2004 | CN1517363A Novel human keratinocyte growth factor mutant |
| 08/04/2004 | CN1517126A Drug compastion with thrombolysis, anti-inflammatory and cell protective function |
| 08/04/2004 | CN1517125A Recombination human granul ocyte-macrophage colong stimulating factor ges and its preparation method |
| 08/04/2004 | CN1517117A Chinese medicine combined with acupoint treatment for curing hypertension etc. disease |
| 08/04/2004 | CN1517113A Ointment for treating burn and scald and its preparation method |
| 08/04/2004 | CN1517092A Compound preparation fortreating psoriasis vulgaris and its preparation process |
| 08/04/2004 | CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160343C Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 08/04/2004 | CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 08/04/2004 | CN1160115C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 08/04/2004 | CN1160100C Ointment for treating burn and scald |
| 08/04/2004 | CN1160093C Psoriasis treating capsule and its prepn. method |
| 08/04/2004 | CN1160088C Extraction method of pharmaceutical composition and cosmetic composition |
| 08/04/2004 | CN1160082C Medicine for curing burn and scald and its preparing method |
| 08/04/2004 | CN1160077C External-used medicine containing phosphonomycin calcium and its application |
| 08/04/2004 | CN1160053C Niacinamide compsns. with reduced tack |
| 08/04/2004 | CN1160052C Amino substituted hydroxy-diphenylone as light stability ultraviolet fitering agent used in cosmetic and pharmaceutical preparation |
| 08/04/2004 | CN1159999C Healthy shoes of konjaku |
| 08/03/2004 | US6770778 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770455 Preparation, use and medicaments containing ribonucleotide polypeptides or their molecular-biological equivalent structures and/or parts and/or derivatives |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 08/03/2004 | CA2456035A1 Use of n-ary n-arylmethyleneiminodiacetates or n, n1-diarylmethylene ethylenediamineacetates as sources of no lmethylene ethylenediaminetriacetates |
| 08/03/2004 | CA2456031A1 Use of mono- or di-esters of cinnamic acid or one of its derivatives and vitamin c, as a source of no |
| 08/03/2004 | CA2310207C Topical zinc compositions and methods of use |
| 08/03/2004 | CA2110161C Medetomidine preparations for transdermal administration |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062678A1 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside |
| 07/29/2004 | WO2004062675A1 Method of modulating il-6 |
| 07/29/2004 | WO2004062659A1 Methods and compositions for preventing/reducing the severity of side effects of chemotherapy and/or radiotherapy |
| 07/29/2004 | WO2004062637A1 Cosmetic composition comprising a metalloproteinase inhibitor and a lipopeptide |
| 07/29/2004 | WO2004050086A8 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004013091A3 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003090640A3 Microbial cellulose wound dressing for treating chronic wounds |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |